Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1150-4,09
KB-0,40
PKN124,66124,76-3,28
Msft379,65379,680,20
Nokia11,7911,805-2,48
IBM251,48251,53-4,15
Mercedes-Benz Group AG44,67544,69-4,60
PFE25,2325,24-2,64
18.06.2026 19:43:58
Indexy online
AD Index online
select
AD Index online
 

  • 18.06.2026 16:31:30
Carl Zeiss Medi (AFXG.SG, Stuttgart)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
24,56 -2,07 -0,52 18 423
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 18.06.2026
Popis společnosti

Business Summary: Carl Zeiss Meditec AG is a Germany-based medical technology and device company. The Company offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The Company offers related support services.
Financial Summary: BRIEF: For the six months ended 31 March 2026, Carl Zeiss Meditec AG revenues decreased 6% to EUR991M. Net income applicable to common stockholders decreased 76% to EUR14.7M. Revenues reflect Ophthalmology segment decrease of 7% to EUR753.8M, Microsurgery segment decrease of 2% to EUR237.2M, Asia/Pacific Region segment decrease of 10% to EUR397.9M, Americas segment decrease of 11% to EUR247.1M.



  • Poslední aktualizace: 18.06.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Group Chief Executive Officer, Executive DirectorAmanda Blanc5706.07.202006.07.2020
Group Chief Financial Officer, Executive DirectorCharlotte Jones-05.09.202205.09.2022
Group Company SecretarySusan Adams-08.01.202408.01.2024